Cargando…
Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery
The coronavirus disease 2019 (COVID-19) global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected over 200 countries and territories worldwide and resulted in more than 2.5 million deaths. In a pressing search for treatments and vaccines, research...
Autores principales: | Giani, Alice Maria, Chen, Shuibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979422/ https://www.ncbi.nlm.nih.gov/pubmed/33677394 http://dx.doi.org/10.1016/j.scr.2021.102207 |
Ejemplares similares
-
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
por: Yang, Liuliu, et al.
Publicado: (2020) -
SARS‐CoV‐2 research using human pluripotent stem cells and organoids
por: Deguchi, Sayaka, et al.
Publicado: (2021) -
Drug Inhibition of SARS-CoV-2 Replication in Human Pluripotent Stem Cell–Derived Intestinal Organoids
por: Krüger, Jana, et al.
Publicado: (2020) -
Modeling cancer progression using human pluripotent stem cell-derived cells and organoids
por: Zhang, Meili, et al.
Publicado: (2020) -
Commentary: A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids
por: Ardestani, Amin, et al.
Publicado: (2020)